Strategic OEM Partnerships Invibio specializes in partnering with medical device manufacturers across the product lifecycle to bring innovative biomaterial solutions to market faster. Its PEEK-OPTIMA polymers offer a non-metal alternative with extensive clinical history and broad adoption in spine, trauma, and orthopedics implants. Growth opportunities include targeting OEMs in those segments to adopt Invibio materials for new devices, expanding co-development programs, and leveraging supply chain and regulatory support to speed time to market.
Additive Manufacturing Focus With the launch of PEEK-OPTIMA AM Filament and ongoing focus on additive manufacturing collaborations, Invibio is positioned to serve design iterations and patient-specific implants. Opportunities exist to supply AM grade materials to 3D printing service bureaus, device developers, and contract manufacturers, plus offer design-for-additive guidance and regulatory-compliant processes to accelerate prototyping and production.
Ultra-Reinforced Trauma Recent collaboration with Paragon Medical to develop ultra-reinforced composite PEEK-OPTIMA trauma devices signals a path to high-strength, lighter-weight implants that avoid metals. Target customers include trauma and orthopedic device manufacturers seeking non-metal, high-strength solutions, with joint development and contract manufacturing partnerships as key entry points.
Regulatory Partnership Pathways Regulatory progress with collaboration partners demonstrates Invibio's capability to support IDE submissions and regulatory clearances for PEEK-based implants. Use this to engage early-stage device developers pursuing regulatory pathways, offering biomaterial selection, clinical history context, and scalable manufacturing to de-risk regulatory timelines.
Global Network Advantage Being part of the Victrex group provides a proven clinical track record and a global implant footprint, aiding market entry and distribution. Leverage the global network and existing hospital relationships to expand in spine, trauma, and orthopedics markets, cross-sell complementary Victrex materials, and scale downstream partnerships with device manufacturers globally.